Hyperparathyroidism is a common endocrine disorder with potential complications on the
skeletal, renal, neurocognitive and cardiovascular systems. While most cases (95%) occur …

Background Parathyroid carcinoma is a rare neoplasm that may present sporadically or in
the context of a genetic syndrome. Diagnosis and management are challenging due to the …

Background: Parathyroid carcinoma (PC) is rare and diagnostically challenging. Reported
outcomes are rather poor and the incidence might be increasing. Material and methods: We …

Parathyroid carcinoma is a rare type of endocrine cancer, with significant morbidity and
mortality associated with parathyroid hormone (PTH)-mediated hypercalcemia. Concerning …

Parathyroid carcinoma is a malignant neoplasm affecting 0.5 to 5.0% of all patients suffering
from primary hyperparathyroidism. This cancer continues to cause challenges for diagnosis …

Background: Cancer stem cells (CSCs) are biologically characterized by self-renewal, multi-
directional differentiation and infinite proliferation, inducing anti-tumor drug resistance and …

Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms with distinct
biological behaviors, depending on the site of origin and the degree of tumor proliferation …

PARAT, a new European Society of Endocrinology program, aims to identify unmet scientific
and educational needs of parathyroid disorders, such as primary hyperparathyroidism …

Background Parathyroid cancer is rare. Differentiating parathyroid carcinoma from
degenerative changes at histopathology can be difficult and studies investigating the value …

Objective Parathyroid carcinoma (PC) is a rare disease which is difficult to diagnose
preoperatively and predict prognosis. The goal of this study was to analyse the preoperative …